Market Overview

Why Is Sangamo Therapeutics Moving?


Shares of Sangamo Therapeutics Inc (NASDAQ: SGMO) are higher by 7.6% Monday afternoon.

Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.

Sangamo Therapeutics shares are trading higher after the company presented data from its Phase 1/2 Alta study evaluating investigational SB-525 gene therapy in patients with severe hemophilia A over the weekend.

Photo taken from the ‘Overview’ Details tool inside Benzinga Pro.

For live updates on SGMO, log in or try Benzinga Pro today.

Posted-In: News Intraday Update Movers Trading Ideas


Related Articles (SGMO)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

'A Necessary Positive Step Forward': XpresSpa Unveils Initiatives To Improve Liquidity, Capital Structure

Why Is Taronis Technology Moving?